Skip to main content
. 2020 Feb 18;2020:8321732. doi: 10.1155/2020/8321732

Table 2.

Effects of TGF-β1 on liver fibrosis indexes (mean ± SD, n = 3).

Group Dose (ng·mL−1) LN (μg·L−1) HA (ng·L−1) PCIII (μg·L−1)
Blank control 51.8 ± 0.78 26.9 ± 5.67 18.8 ± 4.53
Model group (TGF-β1) 100 833.4 ± 9.94## 302.3 ± 7.44## 115.3 ± 3.38##

Compared with the blank control group (#P < 0.05, ##P < 0.01).